A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies
about
Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensThe HIV glycan shield as a target for broadly neutralizing antibodiesRecent strategies targeting HIV glycans in vaccine designStructural insights on the role of antibodies in HIV-1 vaccine and therapyAntibody responses to envelope glycoproteins in HIV-1 infectionStructure and Dynamics of the Native HIV-1 Env TrimerA Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV ImmunogenComputational Refinement and Validation Protocol for Proteins with Large Variable Regions Applied to Model HIV Env Spike in CD4 and 17b Bound State.Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsCrystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 EnvMaturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyStructures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designCrystal Structure of a Soluble Cleaved HIV-1 Envelope TrimerCryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope TrimerAntibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope SpikeStructural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.Progress in HIV-1 vaccine development.Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GSomatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing AntibodiesNatively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding siteNew concepts in HIV-1 vaccine developmentProtein Crystallography in Vaccine Research and DevelopmentAntibody potency relates to the ability to recognize the closed, pre-fusion form of HIV EnvStructural Constraints Determine the Glycosylation of HIV-1 Envelope TrimersCell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 EnvelopeImmunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesAn efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodiesThermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing AntibodiesHIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersStructure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyComposition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope GlycoproteinAsymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.Pre-fusion structure of a human coronavirus spike protein.Current views on the potential for development of a HIV vaccine.Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimersRedesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen.Lessons learned from human HIV vaccine trials.
P2860
Q26772129-711C7C41-8B86-4A83-87FE-D1F5E001AE7EQ26777382-2CFB00D8-8909-4B59-B037-FEA00129CA49Q26786540-C9870DA6-6B49-4483-A6B7-02F07A7B9C4FQ26823603-F1326FEC-5A4A-4824-996A-3062A738E59AQ26829461-E002877D-E25B-4E47-9749-DC0E05025423Q26991572-49F559A8-304B-4516-A65B-646F0508D8A0Q27027570-B0AB2B8C-C78F-41BD-B1AF-7F424F0BFEA4Q27302081-FE594CAA-13AD-4047-90D2-EE7ED54C895FQ27303608-218C0C45-9380-4A73-A2E2-C934815C921FQ27320687-AFAEB23A-8E20-4D2D-B59C-777E149367D2Q27644383-E847EC60-BAE9-4205-922A-10FE7EE710A1Q27644415-BEDE14C3-0A95-42B6-B7F2-8E050ADC91D8Q27644634-DD71DB8F-0100-4267-9DF7-26F9E687C6FDQ27680496-144B17B4-9332-49A7-8807-933E0BC61E66Q27680497-E7E9F4DC-70C7-410E-879A-29BFB4A86AA7Q27683540-CB3F8306-A616-4AEB-A333-AAB94D852EDDQ27683553-7CDD3839-56F8-4F68-967A-9D91995CACA5Q27693849-1437A669-3802-43F0-B306-9B7333305187Q27704710-E030620E-B977-424D-9007-208508FF837CQ27723297-93C5D4BD-DE75-4F0F-A326-EE7AF2FC8726Q27728037-1F62881A-768E-43E6-8B6C-59A7D7D6F098Q28067027-2B64F336-5093-4D16-AE0E-B2C238BDB1E4Q28087528-7004E5DE-C61D-4CEB-8009-46D3BF4CDC65Q28256508-651BE70F-A95E-45DB-81BC-CB157D8DF1F1Q28263063-8BCC797B-9EA7-411D-A59E-C28756E77067Q28263655-B1FD88FF-4C57-4072-8590-59E0F25040EFQ28271300-FECAD0DE-AB83-49DC-AC6F-581745224A87Q28545185-5A7E121A-D2E5-4C5E-A929-DA9EFD9062CAQ28553360-5F472560-FFE6-4522-BCD4-124337F693D6Q28647225-4C356909-F9FC-4FA6-B89F-ED88A426FACCQ28654490-AE448CC0-0173-4834-9011-8C9EC5CAFBD5Q29306052-F829D616-D767-47F0-8E04-FDF36D957F5DQ30352300-48AF2A0C-5A50-4E27-B034-559C25CDEB2EQ30385177-767ECB5D-1E7B-4E4B-9685-97E4F33D5A0EQ30397595-CD3C1349-624C-43D1-BBDA-3B442B2EF229Q30490942-0CC82131-2543-452D-BECF-37BF7C8DDDE4Q30580101-D4FC35A7-9713-4C67-A6A1-D3ECB5486456Q30657338-EFFE0683-B75A-4E83-8928-B595CB0D7492Q33365688-8518DD8C-4414-4119-88D3-33E1155A3853Q33557844-1E19DA17-1F6A-4E12-9E67-04E7CBB6A178
P2860
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@ast
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@en
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@nl
type
label
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@ast
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@en
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@nl
prefLabel
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@ast
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@en
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@nl
P2093
P2860
P50
P3181
P1433
P1476
A next-generation cleaved, sol ...... ot non-neutralizing antibodies
@en
P2093
Alba Torrents de la Peña
Albert Cupo
Andrew B Ward
Anila Yasmeen
C Richter King
Claudia Blattner
Helen J Kim
Jacob Korzun
John P Moore
Kevin de Los Reyes
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003618
P407
P577
2013-09-01T00:00:00Z